Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' reply.
Vince B C BiemansFrank HoentjenMarieke J PierikPublished in: Alimentary pharmacology & therapeutics (2020)